Logo image
Targeting Calpain for Heart Failure Therapy: Implications From Multiple Murine Models
Journal article   Open access   Peer reviewed

Targeting Calpain for Heart Failure Therapy: Implications From Multiple Murine Models

Yihui Wang, Biyi Chen, Chun-Kai Huang, Ang Guo, Jennifer Wu, Xiaoming Zhang, Rong Chen, Cheng Chen, William Kutschke, Robert M Weiss, …
JACC. Basic to translational science, Vol.3(4), pp.503-517
08/01/2018
DOI: 10.1016/j.jacbts.2018.05.004
PMID: 30175274
url
https://doi.org/10.1016/j.jacbts.2018.05.004View
Published (Version of record) Open Access

Abstract

• Calpain is hyperactivated in human failing hearts and rodent heart failure models of different etiologies. • Inhibition of calpain activity with MDL-28170 protects against cardiac dysfunction by preserving JP2 expression and T-tubule ultrastructural integrity in murine models of heart failure. • Overexpression of JP2 delays the onset of early cardiac sudden death and heart failure, induced by calpain overactivation. Heart failure remains a major cause of morbidity and mortality in developed countries. There is still a strong need to devise new mechanism-based treatments for heart failure. Numerous studies have suggested the importance of the Ca 2+ -dependent protease calpain in cardiac physiology and pathology. However, no drugs are currently under development or testing in human patients to target calpain for heart failure treatment. Herein the data demonstrate that inhibition of calpain activity protects against deleterious ultrastructural remodeling and cardiac dysfunction in multiple rodent models of heart failure, providing compelling evidence that calpain inhibition is a promising therapeutic strategy for heart failure treatment.
heart failure RV, right ventricular calcium TAB, transverse aortic banding WT, wild-type LV, left ventricle SR, sarcoplasmic reticulum PRECLINICAL RESEARCH TTpower, strength of regularity of the T-tubule system ventricular MI, myocardial infarction E-C coupling, excitation-contraction coupling JP2, junctophilin-2 calpain IP, intraperitoneally T-tubules ISO, isoproterenol JP2-OE, junctophilin-2 overexpressing T-tubule, transverse tubule EF, ejection fraction CAPN1-OE, calpain-1 overexpressing excitation-contraction coupling

Details

Metrics

Logo image